GSK PLC CEDEAR EACH REPR 1/4 ADRGSK PLC CEDEAR EACH REPR 1/4 ADRGSK PLC CEDEAR EACH REPR 1/4 ADR

GSK PLC CEDEAR EACH REPR 1/4 ADR

Nessun attività
Visualizza sui grafici

Obbligazioni GSK

Di seguito è riportato l'elenco delle obbligazioni societarie GSK PLC CEDEAR EACH REPR 1/4 ADR. Gli investitori spesso optano per le obbligazioni di una società per la loro maggiore stabilità in tempi di volatilità del mercato. Studia i prezzi, i rendimenti e altre statistiche per trovare un investimento affidabile.
Simbolo
YTM %
Volume
Prezzo %
Cedola %
Data di maturazione
Importo in eccesso
Valore nominale
Importo min. denominazione
Emittente
XXS217060907GLAXOSM.CAP. MTN 20/35MTN
6,09%072,58%1,63%2035-05-12750 M GBP1.000,00 GBP100.000,00 GBPGlaxoSmithKline Capital Plc
117RIGLAXOSMITHKLINE CAPITAL PLC 4.25% GTD SNR EMTN 18/12/456,06%8,46 K82,51%4,25%2045-12-18370,79 M GBP1.000,00 GBP100.000,00 GBPGlaxoSmithKline Capital Plc
GGSK3981911GlaxoSmithKline Capital, Inc. 4.2% 18-MAR-2043
5,96%60 K84,83%4,20%2043-03-18500 M USD1.000,00 USD2.000,00 USDGlaxoSmithKline Capital, Inc.
883GIGLAXOSMITHKLINE CAPITAL PLC 5.25% GTD SNR EMTN 10/04/20425,91%094,48%5,25%2042-04-10477,82 M GBP1.000,00 GBP50.000,00 GBPGlaxoSmithKline Capital Plc
771ZCGLAXOSMITHKLINE CAPITAL PLC 6.375% GTD SNR EMTN 09/03/395,40%0107,63%6,38%2039-03-09631,3 M GBP1.000,00 GBP50.000,00 GBPGlaxoSmithKline Capital Plc
GGSK6023693GlaxoSmithKline Capital, Inc. 4.875% 15-APR-2035
5,04%510 K98,94%4,88%2035-04-15750 M USD1.000,00 USD2.000,00 USDGlaxoSmithKline Capital, Inc.
GGSK.GJGlaxoSmithKline Capital, Inc. 6.375% 15-MAY-2038
5,02%3,73 M110,58%6,38%2038-05-152,75 B USD1.000,00 USD2.000,00 USDGlaxoSmithKline Capital, Inc.
AAG99GLAXOSMITHKLINE CAPITAL PLC 5.25% GTD SNR EMTN 19/12/20334,69%0103,35%5,25%2033-12-19574,17 M GBP1.000,00 GBP1.000,00 GBPGlaxoSmithKline Capital Plc
772WIGLAXOSMITHKLINE CAPITAL INC 5.375% GTD SNR NTS 15/04/20344,57%0105,28%5,38%2034-04-15500 M USD1.000,00 USD1.000,00 USDGlaxoSmithKline Capital, Inc.
GGSK6023692GlaxoSmithKline Capital Plc FRN 12-MAR-2027
4,53%250 K100,47%4,84%2027-03-12600 M USD1.000,00 USD2.000,00 USDGlaxoSmithKline Capital Plc
UUS377373AH8GLAXOSM.CAP. 19/29
4,42%096,57%3,38%2029-06-011 B USD1.000,00 USD2.000,00 USDGlaxoSmithKline Capital Plc
GGSK6023695GlaxoSmithKline Capital, Inc. 4.5% 15-APR-2030
4,41%5,01 M100,35%4,50%2030-04-15850 M USD1.000,00 USD2.000,00 USDGlaxoSmithKline Capital, Inc.
UUS377372AN7GLAXOSMITHKLINE CAP.18/28
4,33%098,87%3,88%2028-05-151,75 B USD1.000,00 USD2.000,00 USDGlaxoSmithKline Capital, Inc.
XXS217060184GLAXOSM.CAP. MTN 20/28MTN
4,27%091,49%1,25%2028-10-12750 M GBP1.000,00 GBP100.000,00 GBPGlaxoSmithKline Capital Plc
GGSK6023691GlaxoSmithKline Capital Plc 4.315% 12-MAR-2027
4,06%540 K100,39%4,32%2027-03-12400 M USD1.000,00 USD2.000,00 USDGlaxoSmithKline Capital Plc
XXS293369275GSK CAP B.V. 24/36 MTN
3,55%097,60%3,25%2036-11-19600 M EUR1.000,00 EUR100.000,00 EURGSK Capital BV
XXS255381776GSK CAP B.V. 22/32 MTN
3,11%0100,10%3,13%2032-11-28700 M EUR1.000,00 EUR100.000,00 EURGSK Capital BV
XXS293369143GSK CAP B.V. 24/31 MTN
3,04%099,13%2,88%2031-11-19700 M EUR1.000,00 EUR100.000,00 EURGSK Capital BV
XXS182282979GLAXOSM.CAP. MTN 18/30MTN
2,83%095,43%1,75%2030-05-21750 M EUR1.000,00 EUR100.000,00 EURGlaxoSmithKline Capital Plc
XXS168152035GLAXOSM.CAP. MTN 17/29
2,61%095,41%1,38%2029-09-12500 M EUR1.000,00 EUR100.000,00 EURGlaxoSmithKline Capital Plc
XXS255381768GSK CAP B.V. 22/27 MTN
2,36%0101,42%3,00%2027-11-28500 M EUR1.000,00 EUR100.000,00 EURGSK Capital BV
GGX5BGLAXOSM.CAP. MTN 17/26
2,21%098,67%1,00%2026-09-12700 M EUR1.000,00 EUR100.000,00 EURGlaxoSmithKline Capital Plc
XXS182282812GLAXOSM.CAP. MTN 18/26MTN
2,07%099,34%1,25%2026-05-211 B EUR1.000,00 EUR100.000,00 EURGlaxoSmithKline Capital Plc
117RNGLAXOSMITHKLINE CAPITAL PLC 3.375% GTD SNR EMTN 20/12/20270,84%0112,19%3,38%2027-12-20307,77 M GBP1.000,00 GBP100.000,00 GBPGlaxoSmithKline Capital Plc
AAQ72GLAXOSMITHKLINE CAPITAL PLC 0.883% GTD SNR EMTN 21/09/200,88%2028-09-2142,5 B JPY100.000.000,00 JPY100.000.000,00 JPYGlaxoSmithKline Capital Plc